Clinical Trial Update: 18F-FSPG PET/CT as a Non-Invasive Imaging Biomarker for Treatment Response to Chemoradiation in Esophageal Cancer

View source ↗

Summary

This clinical trial update describes a study evaluating 18F-FSPG PET/CT as a non-invasive imaging biomarker to monitor treatment response to chemoradiation in e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• 18F-FSPG

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Esophageal Carcinoma | Status: RECRUITING